Responding To Government, Amgen Tells High Court Review Merited For Enablement Issue
WASHINGTON, D.C. — Two weeks after the U.S. solicitor general (SG) submitted an amicus curiae brief recommending that certiorari be denied in a dispute over the enablement requirement in patent specifications,...To view the full article, register now.
Already a subscriber? Click here to view full article